Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SOC TelemedOntrakViemed HealthcareHemaCareTivity Health
SymbolNASDAQ:TLMDNASDAQ:OTRKNASDAQ:VMDOTCMKTS:HEMANASDAQ:TVTY
Price Information
Current Price$6.92$32.29$10.28$25.31$23.56
52 Week RangeBuyBuyBuyN/ABuy
MarketRank™
Overall Score1.61.70.90.51.0
Analysis Score3.44.32.40.01.3
Community Score3.82.62.12.42.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.00.01.7
Earnings & Valuation Score0.60.60.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$11.40$47.20$12.50N/A$22.13
% Upside from Price Target64.74% upside46.18% upside21.60% upsideN/A-6.09% downside
Trade Information
Market Cap$620.20 million$571.21 million$402.82 million$346.52 million$1.16 billion
BetaN/A2.52N/A1.472.49
Average Volume435,378945,211235,59739,950499,802
Sales & Book Value
Annual RevenueN/A$35.10 millionN/AN/A$1.13 billion
Price / SalesN/A16.27N/AN/A1.03
Cashflow$0.00 per shareN/AN/AN/A$3.64 per share
Price / Cash2,571.92N/AN/AN/A6.48
Book Value$0.61 per share($1.44) per shareN/AN/A$4.73 per share
Price / BookN/A-22.42N/AN/A4.98
Profitability
Net Income$20,000.00$-25,660,000.00N/AN/A$-286,820,000.00
EPSN/A($1.15)N/AN/A$2.02
Trailing P/E Ratio0.00N/A0.000.00N/A
Forward P/E RatioN/AN/A∞∞18.26
P/E GrowthN/AN/AN/AN/A1.60
Net MarginsN/A-43.10%N/AN/A-47.44%
Return on Equity (ROE)N/AN/AN/AN/A128.43%
Return on Assets (ROA)N/A-58.54%N/AN/A6.11%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A3.04%N/AN/A435.23%
Current Ratio0.24%3.59%N/AN/A1.04%
Quick Ratio0.24%3.59%N/AN/A0.88%
Ownership Information
Institutional Ownership Percentage20.70%27.49%N/AN/A91.57%
Insider Ownership PercentageN/A58.20%N/A26.20%11.77%
Miscellaneous
Employees226723511N/A350
Shares Outstanding89.62 million17.69 million39.19 million13.69 million49.23 million
Next Earnings Date6/29/2021 (Estimated)5/6/2021 (Estimated)5/3/2021 (Estimated)N/A5/5/2021 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
SourceHeadline
Tivity Health (NASDAQ:TVTY) Stock Crosses Above Two Hundred Day Moving Average of $19.41Tivity Health (NASDAQ:TVTY) Stock Crosses Above Two Hundred Day Moving Average of $19.41
americanbankingnews.com - April 7 at 1:38 AM
Is Red-Hot Tivity Health Stock Maxed out?Is Red-Hot Tivity Health Stock Maxed out?
schaeffersresearch.com - April 6 at 7:14 PM
KNS Acquisition Corp. -- Moodys assigns first time B2 CFR to KNS Acquisition (Nutrisystem); outlook stableKNS Acquisition Corp. -- Moody's assigns first time B2 CFR to KNS Acquisition (Nutrisystem); outlook stable
finance.yahoo.com - March 30 at 12:07 PM
Brokerages Anticipate Tivity Health, Inc. (NASDAQ:TVTY) to Post $0.29 EPS Brokerages Anticipate Tivity Health, Inc. (NASDAQ:TVTY) to Post $0.29 EPS
americanbankingnews.com - March 28 at 12:26 PM
Tivity Health (NASDAQ:TVTY) Downgraded by Zacks Investment Research to "Hold"Tivity Health (NASDAQ:TVTY) Downgraded by Zacks Investment Research to "Hold"
marketbeat.com - March 25 at 4:36 AM
The Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity HealthThe Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity Health
finance.yahoo.com - March 23 at 9:25 AM
Comparing Tivity Health (NASDAQ:TVTY) & SOC Telemed (NASDAQ:TLMD)Comparing Tivity Health (NASDAQ:TVTY) & SOC Telemed (NASDAQ:TLMD)
americanbankingnews.com - March 22 at 10:46 PM
Tivity Health, Inc. (NASDAQ:TVTY) Receives Consensus Recommendation of "Buy" from AnalystsTivity Health, Inc. (NASDAQ:TVTY) Receives Consensus Recommendation of "Buy" from Analysts
americanbankingnews.com - March 21 at 8:34 AM
TIVITY HEALTH INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and DirectorsTIVITY HEALTH INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors
us.acrofan.com - March 13 at 3:16 AM
TIVITY HEALTH INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tivity Health, Inc. - TVTYTIVITY HEALTH INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tivity Health, Inc. - TVTY
finance.yahoo.com - March 13 at 3:16 AM
TIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn...TIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn...
law.com - March 12 at 5:15 PM
HealthEquity (HQY) Enhances Commuter Offering With New BuyoutHealthEquity (HQY) Enhances Commuter Offering With New Buyout
finance.yahoo.com - March 11 at 12:30 PM
Can You Imagine How Jubilant Tivity Healths (NASDAQ:TVTY) Shareholders Feel About Its 112% Share Price Gain?Can You Imagine How Jubilant Tivity Health's (NASDAQ:TVTY) Shareholders Feel About Its 112% Share Price Gain?
finance.yahoo.com - March 5 at 10:15 AM
Tivity Health (TVTY) Upgraded to Buy: Heres WhyTivity Health (TVTY) Upgraded to Buy: Here's Why
finance.yahoo.com - March 1 at 1:05 PM
TIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. - TVTYTIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. - TVTY
prnewswire.com - February 27 at 1:00 AM
TIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. - TVTYTIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. - TVTY
markets.businessinsider.com - February 26 at 11:27 PM
Tivity Health: Q4 Earnings InsightsTivity Health: Q4 Earnings Insights
finance.yahoo.com - February 25 at 12:43 AM
TIVITY HEALTH DELIVERS SOLID RESULTS FOR FOURTH QUARTER AND FULL YEAR 2020; PROVIDES 2021 FINANCIAL GUIDANCE WITH GROWTH IN REVENUE AND EARNINGSTIVITY HEALTH DELIVERS SOLID RESULTS FOR FOURTH QUARTER AND FULL YEAR 2020; PROVIDES 2021 FINANCIAL GUIDANCE WITH GROWTH IN REVENUE AND EARNINGS
finance.yahoo.com - February 24 at 7:43 PM
TVTY Aug 2021 35.000 callTVTY Aug 2021 35.000 call
uk.finance.yahoo.com - February 14 at 12:47 AM
Tivity Health to Issue Fourth Quarter and Full Year 2020 Financial Results After Market Close on February 24Tivity Health to Issue Fourth Quarter and Full Year 2020 Financial Results After Market Close on February 24
finance.yahoo.com - February 9 at 8:39 AM
Tivity Health, Inc. -- Moodys upgrades Tivity Health, Inc.s CFR to B2; outlook is StableTivity Health, Inc. -- Moody's upgrades Tivity Health, Inc.'s CFR to B2; outlook is Stable
finance.yahoo.com - January 27 at 6:02 PM
Tivity Health Reaches Analyst Target PriceTivity Health Reaches Analyst Target Price
nasdaq.com - January 20 at 10:11 AM
A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)A Look At The Fair Value Of Tivity Health, Inc. (NASDAQ:TVTY)
finance.yahoo.com - January 19 at 4:41 PM
TVTY Jan 2021 10.000 putTVTY Jan 2021 10.000 put
uk.finance.yahoo.com - December 29 at 9:42 PM
TVTY Aug 2021 15.000 putTVTY Aug 2021 15.000 put
uk.finance.yahoo.com - December 25 at 7:48 AM
TVTY May 2021 15.000 putTVTY May 2021 15.000 put
uk.finance.yahoo.com - December 24 at 10:55 PM
DateCompanyBrokerageAction
2/16/2021SOC TelemedCredit Suisse GroupInitiated Coverage
1/28/2021SOC TelemedRoyal Bank of CanadaInitiated Coverage
1/15/2021SOC TelemedBenchmarkInitiated Coverage
1/15/2021SOC TelemedBTIG ResearchDowngrade
11/30/2020SOC TelemedRobert W. BairdInitiated Coverage
11/25/2020SOC TelemedWilliam BlairInitiated Coverage
3/22/2021OntrakCanaccord GenuityUpgrade
3/8/2021OntrakCowenReiterated Rating
3/2/2021OntrakB. RileyLower Price Target
10/28/2020Viemed HealthcareAcumen CapitalReiterated Rating
10/19/2020Viemed HealthcareBloom BurtonReiterated Rating
5/5/2020Viemed HealthcareBeacon SecuritiesReiterated Rating
8/12/2019Viemed HealthcareLake Street CapitalBoost Price Target
11/28/2018HemaCareDougherty & CoReiterated Rating
2/25/2021Tivity HealthPiper SandlerBoost Price Target
2/25/2021Tivity HealthBarrington ResearchBoost Price Target
1/5/2021Tivity HealthTruistBoost Price Target
11/23/2020Tivity HealthGuggenheimUpgrade
11/17/2020Tivity HealthCantor FitzgeraldUpgrade
10/30/2020Tivity HealthJefferies Financial GroupUpgrade
8/6/2020Tivity HealthCraig HallumUpgrade
5/21/2020Tivity HealthSunTrust BanksBoost Price Target
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.